Home » Newsletters » BioWorld Science

BioWorld Science

April 14, 2020

View Archived Issues

Dual mu-opioid/nociceptin receptor agonist BPR-1M97 shows advantages over morphine

Death, taxes and zoonotic spillover

Phase I trial of INO-5150 immunotherapy against PSA/PSMA in biochemically relapsed prostate cancer

An innovative 3D fiber-reinforced hydrogel for the regeneration of corneal stroma

Exosomes deliver sepsis treatment

Dopamine has epigenetic role in addiction

Koselugo receives FDA approval for pediatric patients with NF1-related plexiform neurofibromas

Metacrine patents farnesoid X receptor agonists

SOX4-dependent regulation of a subset of tRNA genes controls human glioblastoma cell proliferation

New melanocortin MC4 receptor agonists identified at Palatin Technologies

Bristol-Myers Squibb discovers lysophosphatidic acid receptor 1 antagonists

Loss-of-function mutation in BK channel reduces mitochondrial viability, causing progressive ataxia

Phase III study of tislelizumab plus chemotherapy in NSCLC meets primary endpoint

Roche, Genentech describe new MAP4K1 inhibitors

FDA lifts clinical hold on phase III study of TG-C

New small-molecule inhibitor of enterovirus 71 for the treatment of hand, foot and mouth disease

Goldfinch Biopharma presents new TRPC5/TRPC4 antagonists

Potent and selective sphingosine kinase 2 inhibitor targeting a small side cavity

Ridgeback Biotherapeutics initiates phase I study of EIDD-2801 for COVID-19

PLOD1 mutation tied to smooth muscle cell dysfunction and aortopathy

Bausch Health initiates clinical trial of Virazole in patients with COVID-19

BioInvent reports early responses in phase I/IIa study of BI-1206 for NHL

AstraZeneca to unblind phase III ADAURA trial of Tagrisso early based on efficacy

Lilly advances plans to evaluate baricitinib and LY-3127804 for COVID-19

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...